From The Economic Times · Ritesh Presswala · · 1m 20s
Sahajanand Medical Technologies IPO Day 3: GMP at 7%
Sahajanand Medical Technologies IPO hits 7% grey market premium as final bidding day approaches.
In brief
Sahajanand Medical Technologies IPO hits 7% grey market premium as final bidding day approaches. Sahajanand Medical Technologies' IPO achieves 82% subscription by Day 2 with a 7% grey market premium indicating potential listing gains. Originally reported by The Economic Times.
IPO Subscription Status
Sahajanand Medical Technologies IPO achieved 82% overall subscription by end of Day 2 against 97.50 lakh shares on offer.
Retail Individual Investors Demand
Retail Individual Investors subscribed 83% of their 47.50 lakh shares reserved for retail investors.
Grey Market Premium
The IPO commands a 7% grey market premium (GMP) of Rs 25 per share indicating potential listing gains.
IPO Price Band
Sahajanand Medical Technologies fixed its IPO price band at Rs 327, 344 per share for the public issue.
Listing Schedule
The shares are tentatively scheduled to list on BSE and NSE on October 23, 2026, after allotment on October 21.
Financial Performance
Total income increased 18% to Rs 1,219 crore in FY26 from Rs 1,036 crore in FY25.
Profit After Tax
Profit after tax surged 175% to Rs 69 crore in FY26, compared with Rs 25 crore in FY25.
IPO Subscription Details
Qualified Institutional Buyers subscribed 1.12 times their reserved portion against 27.14 lakh shares on offer.
The takeaway
Sahajanand Medical Technologies' IPO achieves 82% subscription by Day 2 with a 7% grey market premium indicating potential listing gains.
